- Home
- ASND vs AGNC Comparison
ASND vs AGNC Comparison
Compare ASND & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | AGNC |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.7B |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ASND | AGNC |
|---|---|---|
| Price | $233.32 | $11.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $264.13 | $10.47 |
| AVG Volume (30 Days) | 638.0K | ★ 18.9M |
| Earning Date | 02-11-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 12.20% |
| EPS Growth | N/A | ★ 58.06 |
| EPS | N/A | ★ 1.47 |
| Revenue | $758,592,045.00 | ★ $1,797,000,000.00 |
| Revenue This Year | $99.54 | $13.57 |
| Revenue Next Year | $84.40 | $57.74 |
| P/E Ratio | ★ N/A | $8.03 |
| Revenue Growth | ★ 97.46 | 84.69 |
| 52 Week Low | $118.03 | $7.85 |
| 52 Week High | $238.84 | $11.93 |
Technical Indicators
Market Signals| Indicator | ASND | AGNC |
|---|---|---|
| Relative Strength Index (RSI) | 64.45 | 70.22 |
| Support Level | $200.69 | $11.52 |
| Resistance Level | $238.84 | $11.92 |
| Average True Range (ATR) | 11.62 | 0.21 |
| MACD | 2.42 | 0.03 |
| Stochastic Oscillator | 88.16 | 87.84 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.